3.935
전일 마감가:
$3.69
열려 있는:
$3.74
하루 거래량:
3.26M
Relative Volume:
0.59
시가총액:
$894.81M
수익:
$251.85M
순이익/손실:
$-72.58M
주가수익비율:
-12.56
EPS:
-0.3134
순현금흐름:
$-63.80M
1주 성능:
+8.10%
1개월 성능:
+6.93%
6개월 성능:
-25.25%
1년 성능:
-47.04%
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ARDX
Ardelyx Inc
|
3.935 | 894.81M | 251.85M | -72.58M | -63.80M | -0.3134 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
444.25 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
523.55 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
326.74 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
548.00 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
242.57 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-02 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
2025-03-04 | 개시 | BTIG Research | Buy |
2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-04-05 | 개시 | Leerink Partners | Outperform |
2023-12-18 | 개시 | Raymond James | Strong Buy |
2023-09-07 | 개시 | H.C. Wainwright | Buy |
2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
2021-03-23 | 개시 | Wedbush | Outperform |
2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
2020-10-20 | 재개 | Citigroup | Buy |
2020-02-18 | 재개 | Jefferies | Buy |
2020-02-12 | 개시 | Citigroup | Buy |
2020-02-10 | 개시 | Cowen | Outperform |
2019-04-08 | 개시 | Piper Jaffray | Overweight |
2018-08-24 | 개시 | Jefferies | Buy |
2018-03-19 | 재개 | Leerink Partners | Outperform |
2017-11-29 | 재확인 | Citigroup | Buy |
2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
2017-10-17 | 재개 | Leerink Partners | Outperform |
2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Director David Mott Acquires 200,000 Shares of Ardelyx Inc (ARDX) - GuruFocus
Ardelyx Stockholders Approve Equity Plan Amendment - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - Bluefield Daily Telegraph
ARDX Gains Attention with HC Wainwright & Co. Buy Rating | ARDX Stock News - GuruFocus
H.C. Wainwright assumes coverage on Ardelyx stock with buy rating By Investing.com - Investing.com India
Ardelyx (ARDX) Receives Positive Coverage with Buy Rating and $10 Target | ARDX Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. ... - Bluefield Daily Telegraph
Hedge Fund and Insider Trading News: Paul Tudor Jones, Divya Nettimi, Scott Bessent, Marshall Wace, Warren Buffett, Rokos Capital Management, Ardelyx Inc (ARDX), Ralph Lauren Corp (RL), and More - Insider Monkey
Ardelyx director David Mott acquires $737,260 in stock By Investing.com - Investing.com South Africa
Ardelyx director David Mott acquires $737,260 in stock - Investing.com
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com
Ardelyx is hiring: Director, Marketing in New York at Ardelyx Job - Mediabistro
Transcript : Ardelyx, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - MarketScreener
Ardelyx at Jefferies Conference: Strategic Growth and Market Challenges By Investing.com - Investing.com India
Ardelyx at Jefferies Conference: Strategic Growth and Market Challenges - Investing.com
Ardelyx is hiring: Director, Marketing in Waltham at Ardelyx Job - Mediabistro
Ardelyx reshuffles leadership, adds new HR chief By Investing.com - Investing.com South Africa
Ardelyx appoints Mike Kelliher Chief Business Officer - TipRanks
Ardelyx Promotes Mike Kelliher to Chief Business Officer - marketscreener.com
Ardelyx reshuffles leadership, adds new HR chief - Investing.com Australia
Ardelyx (ARDX) Appoints New Leadership in Strategic Roles | ARDX Stock News - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer - marketscreener.com
Ardelyx Appoints Mike Kelliher Chief Business Officer and James - GuruFocus
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer - The Manila Times
Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer | ARDX Stock News - GuruFocus
Ardelyx Expands Leadership: Strategic Promotion and Key Executive Hire Signal Growth Push - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
Ardelyx, Inc. (ARDX) Stock Analysis: Investors Eye a Promising 167.99% Upside Potential - DirectorsTalk Interviews
Learn to Evaluate (ARDX) using the Charts - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
2 ‘Strong Buy’ Small-Cap Stocks With Blockbuster Potential - The Globe and Mail
Deutsche Bank AG Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx chief medical officer sells shares worth $26,206 By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock By Investing.com - Investing.com South Africa
Ardelyx chief medical officer sells shares worth $26,206 - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock By Investing.com - Investing.com South Africa
Ardelyx CFO sells $29,459 in stock - Investing.com Australia
Ardelyx officer Mike Kelliher sells $59,270 in stock - Investing.com Australia
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ardelyx Inc 주식 (ARDX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
MOTT DAVID M | Director |
Jun 09 '25 |
Buy |
3.69 |
200,000 |
737,260 |
2,696,871 |
Williams Laura A | Chief Medical Officer |
May 20 '25 |
Sale |
4.08 |
6,421 |
26,207 |
402,583 |
Renz Justin A | Chief Financial Officer |
May 20 '25 |
Sale |
4.08 |
7,218 |
29,460 |
416,089 |
RAAB MICHAEL | President & CEO |
May 20 '25 |
Sale |
4.08 |
46,817 |
191,079 |
1,547,937 |
Kelliher Mike | See Remarks |
May 20 '25 |
Sale |
4.08 |
14,522 |
59,270 |
282,158 |
GRAMMER ELIZABETH A | See Remarks |
May 20 '25 |
Sale |
4.08 |
5,992 |
24,456 |
311,731 |
Foster Eric Duane | Chief Commercial Officer |
May 20 '25 |
Sale |
4.08 |
2,507 |
10,232 |
316,806 |
MOTT DAVID M | Director |
May 15 '25 |
Buy |
3.29 |
100,000 |
329,120 |
2,496,871 |
MOTT DAVID M | Director |
May 02 '25 |
Buy |
4.22 |
381,377 |
1,610,936 |
2,396,871 |
RAAB MICHAEL | President & CEO |
May 02 '25 |
Option Exercise |
0.99 |
20,833 |
20,625 |
1,636,420 |
자본화:
|
볼륨(24시간):